Your Article Summary
See Latest ArticlesInsomnia-related comorbidities and economic costs among a commercially insured population in the United States
Current Medical Research and Opinion, 06/29/09
Pollack M et al. - Though identified patients were required to have enrollment in both medical and productivity databases, and the presence of insomnia could not be verified through medical records, these results suggest a significant link between insomnia and higher rates of comorbid conditions, healthcare expenditures and productivity losses. Payers and employers should consider insomnia as a factor in disease-related case-management initiatives.
Related Articles
Examining maladaptive beliefs about sleep across insomnia patient groups
Journal of Psychosomatic Research, 11/09/09
Relevance Score: 91%
Psychosocial job characteristics and insomnia: A prospective cohort study using the Demand-Control-Support (DCS) and Effort–Reward Imbalance (ERI) job stress models
Sleep Medicine, 11/18/09
Relevance Score: 89%
Does mental health history explain gender disparities in insomnia symptoms among young adults?
Sleep Medicine, 11/16/09
Relevance Score: 87%
Computer Based Synchronization Analysis on Sleep EEG in Insomnia
The Journal of Medical Systems, 10/26/09
Relevance Score: 87%
Singular Spectrum Analysis of Sleep EEG in Insomnia
The Journal of Medical Systems, 10/08/09
Relevance Score: 87%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
Acta Neurologica Scandinavica, 12/01/09
Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease
Parkinsonism & Related Disorders, 12/01/09
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Economic Evaluation of Pharmacotherapy of Migraine Pain: A Review of the Literature
Journal Of Pain & Palliative Care Pharmacotherapy, 12/02/09
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Infection Control and Hospital Epidemiology, 12/02/09
Healthcare Costs and Obesity Prevention: Drug Costs and Other Sector-Specific Consequences
PharmacoEconomics, 11/30/09